approval · primary record
TRASTUZUMAB AND HYALURONIDASE-OYSK
FDA · BLA · 2026-05-18
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-05-18 |
| Brand | HERCEPTIN HYLECTA |
| Sponsor | GENENTECH INC |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:31:17.172Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:TRASTUZUMAB AND HYALURONIDASE-OYSK:2026-05-18
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.